Fotios Plakogiannis
Gründer bei Transdermal Research Pharm Laboratories LLC
Aktive Positionen von Fotios Plakogiannis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Transdermal Research Pharm Laboratories LLC | Gründer | 01.01.2013 | - |
| Präsident | 01.01.2013 | - | |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Fotios Plakogiannis
Ehemalige bekannte Positionen von Fotios Plakogiannis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 03.01.2014 | 10.07.2018 |
| Vorsitzender | 25.02.2013 | 10.12.2014 | |
| Gründer | 03.01.2013 | 10.07.2018 | |
| Long Island University | Corporate Officer/Principal | 01.01.1967 | 01.01.2011 |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Corporate Officer/Principal | - | - |
Ausbildung von Fotios Plakogiannis
| The Ohio State University | Graduate Degree |
| University of Southern California | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Kanada | 2 |
Operativ
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Transdermal Research Pharm Laboratories LLC | |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
- Börse
- Insiders
- Fotios Plakogiannis
- Erfahrung
